These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 2128608)

  • 21. Sulphadiazine-resistant group A meningococci isolated during the 1968 meningitis epidemic in Greece.
    Vassiliadis P; Kanellakis A; Papadakis J
    J Hyg (Lond); 1969 Jun; 67(2):279-88. PubMed ID: 4978421
    [No Abstract]   [Full Text] [Related]  

  • 22. Failures of rifampicin and ciprofloxacin to eradicate a susceptible meningococcal isolate from a close contact of a fatal case.
    Tsakris A; Trakatelli C; Souliou E; Sofianou D; Ntoutsou K; Antoniadis A
    Infection; 2001 Oct; 29(5):293-4. PubMed ID: 11688913
    [No Abstract]   [Full Text] [Related]  

  • 23. Intrafamilial infection with Neisseria meningitidis, group C. An intense intramural meningeal infestation in a family.
    Martin GI; DeGrinney JT
    Clin Pediatr (Phila); 1972 Sep; 11(9):538-40. PubMed ID: 4627455
    [No Abstract]   [Full Text] [Related]  

  • 24. [Meningococcal epidemic in a boarding school: a rifampicin-resistant secondary case while under chemoprophylaxis].
    Schubiger G; Munzinger J; Dudli C; Wipfli U
    Schweiz Med Wochenschr; 1986 Aug; 116(35):1172-5. PubMed ID: 3094142
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Meningococcal colonization and infection in children and their household contacts.
    Marks MI; Frasch CE; Shapera RM
    Am J Epidemiol; 1979 May; 109(5):563-71. PubMed ID: 110143
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Occupational transmission of Neisseria meningitidis --- California, 2009.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2010 Nov; 59(45):1480-3. PubMed ID: 21085089
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rifampin-resistant Neisseria meningitidis.
    Taha MK; Zarantonelli ML; Ruckly C; Giorgini D; Alonso JM
    Emerg Infect Dis; 2006 May; 12(5):859-60. PubMed ID: 16710955
    [No Abstract]   [Full Text] [Related]  

  • 28. [Examination of the environment in meningococcal disease. Identification and clearing of the virulent microorganism from the environment of patients with meningococcal disease].
    Kristiansen BE; Tveten Y; Ask E; Knapskog AB; Reiten T; Steen-Johnsen J; Hopen G
    Tidsskr Nor Laegeforen; 1989 May; 109(13):1373-6. PubMed ID: 2501905
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Have South Australian isolates of Neisseria meningitidis become less susceptible to penicillin, rifampicin and other drugs? A study of strains isolated over three decades, 1971-1999.
    Hansman D; Wati S; Lawrence A; Turnidge J
    Pathology; 2004 Apr; 36(2):160-5. PubMed ID: 15203752
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Meningococcus carriers].
    Corey G; Rodríguez H; Aguilar C; Greve E; Bustos R; Valenzuela ME
    Bol Oficina Sanit Panam; 1979 Sep; 87(3):238-46. PubMed ID: 159065
    [No Abstract]   [Full Text] [Related]  

  • 31. Emergence of fluoroquinolone-resistant Neisseria meningitidis--Minnesota and North Dakota, 2007-2008.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Feb; 57(7):173-5. PubMed ID: 18288075
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Meningococcal meningitis in Italy: 1887-1986].
    Ballada D; Ventura G; Tumbarello M; Cauda R; Toti L; Ortona L
    Medicina (Firenze); 1990; 10(2):129-33. PubMed ID: 2125677
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In-vitro and in-vivo studies of resistance to rifampin in meningococci.
    Eickhoff TC
    J Infect Dis; 1971 Apr; 123(4):414-20. PubMed ID: 4999905
    [No Abstract]   [Full Text] [Related]  

  • 34. A first meningococcal meningitis case caused by serogroup X Neisseria meningitidis strains in China.
    Chen C; Zhang TG; He JG; Wu J; Chen LJ; Liu JF; Pang XH; Yang J; Shao ZJ; Huang YC
    Chin Med J (Engl); 2008 Apr; 121(7):664-6. PubMed ID: 18466690
    [No Abstract]   [Full Text] [Related]  

  • 35. Efficacy of rifampin in treatment of meningococcal carriers.
    Deal WB; Sanders E
    N Engl J Med; 1969 Sep; 281(12):641-5. PubMed ID: 4980025
    [No Abstract]   [Full Text] [Related]  

  • 36. Carrier rate of Neisseria meningitidis and the occurrence of sulfonamide resistant strains in Lebanon.
    Uwaydah M
    J Med Liban; 1973; 26(5):495-500. PubMed ID: 4205464
    [No Abstract]   [Full Text] [Related]  

  • 37. Nasopharyngeal, vaginal and anal carriage of Neisseria meningitidis in Nigeria.
    Gugnani HC; Uganabo JA
    J Commun Dis; 1989 Mar; 21(1):41-5. PubMed ID: 2509546
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Meningococcal infection in Egypt: laboratory findings in meningitis patients and the prevalence of pharyngeal infection in patients and contacts.
    Sippel JE; Girgis NI
    Am J Trop Med Hyg; 1978 Sep; 27(5):980-5. PubMed ID: 102212
    [No Abstract]   [Full Text] [Related]  

  • 39. Active surveillance of meningococcal meningitis in Poland.
    Tyski S; Grzybowska W; Lind I
    Cent Eur J Public Health; 1998 Aug; 6(3):219-24. PubMed ID: 9787924
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hajj-associated outbreak strain of Neisseria meningitidis serogroup W135: estimates of the attack rate in a defined population and the risk of invasive disease developing in carriers.
    Wilder-Smith A; Goh KT; Barkham T; Paton NI
    Clin Infect Dis; 2003 Mar; 36(6):679-83. PubMed ID: 12627350
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.